These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11190459)

  • 1. [Microabluminuria in arterial hypertension. Measurement, variables, interpretation, recommendations].
    Hornych A; Marre M; Mimran A; Chaignon M; Asmar R; Fauvel JP;
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11):1304-8. PubMed ID: 11190459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria as an early marker for cardiovascular disease.
    de Zeeuw D; Parving HH; Henning RH
    J Am Soc Nephrol; 2006 Aug; 17(8):2100-5. PubMed ID: 16825327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria in essential hypertension.
    Crippa G
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microalbuminuria in arterial hypertension].
    Pérez-Blanco FJ; Azcón González De Aguilar P; Miras Parra FJ; Morales Camacho L
    An Med Interna; 1998 Jul; 15(7):381-3. PubMed ID: 9710992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of microalbuminuria as a cardiovascular risk indicator: A review.
    Diercks GF; van Boven AJ; Hillege JL; de Jong PE; Rouleau JL; van Gilst WH
    Can J Cardiol; 2002 May; 18(5):525-35. PubMed ID: 12032579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microalbuminuria: do we need a new threshold?
    Zamora CR; Cubeddu LX
    J Hum Hypertens; 2009 Feb; 23(2):146-9. PubMed ID: 18784737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microalbuminuria, hypertension, and cardiovascular risk].
    Deferrari G; Pontremoli R
    Cardiologia; 1994 Dec; 39(12 Suppl 1):159-62. PubMed ID: 7634260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary albumin and cardiovascular profile in the middle-aged population.
    Cirillo M; Lombardi C; Bilancio G; Chiricone D; Stellato D; De Santo NG
    Semin Nephrol; 2005 Nov; 25(6):367-71. PubMed ID: 16298257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic kidney disease and global cardiovascular risk in essential hypertension.
    Segura J; Campo C; Ruilope LM
    Minerva Med; 2004 Oct; 95(5):375-83. PubMed ID: 15467513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria and hypertension.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microalbuminuria is associated with a fourfold increased risk of ischemic heart disease among hypertensive patients].
    Jensen JS; Feldt-Rasmussen BF; Strandgaard S; Schroll M; Borch-Johnsen K
    Ugeskr Laeger; 2002 Aug; 164(32):3773-7. PubMed ID: 12362612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microalbuminuria in hypertensive, non-proteinuric renal transplant recipients: role of previous acute rejection episodes and sodium intake].
    Halimi JM; al-Najjar A; Buchler M; Giraudeau B; Etienne I; Picou S; Marlière J; Nivet H; Lebranchu Y
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):933-6. PubMed ID: 11575234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance of transferrinuria and albumin-specific dipstick testing in primary care patients with elevated office blood pressure.
    Zeller A; Haehner T; Battegay E; Martina B
    J Hum Hypertens; 2005 Mar; 19(3):205-9. PubMed ID: 15549141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global risk stratification in primary hypertension: the role of the kidney.
    Leoncini G; Ratto E; Viazzi F; Conti N; Falqui V; Parodi A; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Mar; 26(3):427-32. PubMed ID: 18300851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuria: natural course, prognostic implications and therapeutic considerations.
    Sarafidis PA
    Minerva Med; 2007 Dec; 98(6):693-711. PubMed ID: 18299683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular risk.
    Segura J; Ruilope LM
    Fundam Clin Pharmacol; 2005 Aug; 19(4):429-37. PubMed ID: 16011729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.